A non-profit research institute in Strasbourg, Gepromed unites device testing, simulation-based surgical training, clinical monitoring and explant analysis within a single implant cycle.
practitioners trained since 2018
average satisfaction
expert supervisors
They support us
Patient safety, continuously monitored
Surgical safety: our 3 platforms
Gepromed connects explant analysis, technical testing and a digital twin to reduce avoidable complications and make implantable medical devices safer.
- 01
Explant Analysis
Researchers, health authorities, manufacturersAn explanted device is evidence: it can document why and how an implant failed, and it also reveals how the device behaved. Since its creation, Gepromed has analyzed more than 1,800 explanted implantable medical devices under standardized protocols. That work has fed nearly 290 scientific publications.
- 02
Testing Technology Park (ISO 13485)
Industry & manufacturersBefore a medical device reaches an operating room, it must supply technical proof of its safety and performance. Gepromed gives manufacturers — from small structures to large industrial groups — a park of mechanical and hydraulic test benches (tensile, fatigue, permeability, compliance), operated under ISO 13485 certification. Gepromed is neither a manufacturer nor a notified body: that independence is what makes the results credible.
- 03
Simulation & Digital-Twin Education
Surgeons, residents, OR nurses, biomedical engineersMore than 1,800 healthcare professionals — surgeons, residents, operating-room nurses, biomedical engineers — have been trained by Gepromed since 2018, on a broad park of immersive surgical simulators and two connected operating rooms, with a satisfaction rate above 95%. Gepromed is now developing a surgical digital twin to objectify practitioners' technical performance and detect at-risk situations before they occur.
A built-in safety loop
- 01Explant analysis identifies the real causes of an implant's failure.
- 02Those observations guide the technical testing protocols, which validate or objectify device performance before release.
- 03The clinical and technical data feed the simulation and the surgical digital twin, which train and certify practitioners on realistic scenarios.
- 04The resulting clinical practice in turn generates new data — and new explants — which close the loop.
It is at this convergence of research, teaching and practice that Gepromed positions itself as a European hub for the surgery of the future.
A public health issue
In Europe, more than 12 million patients now carry an implantable medical device. In France, the cost of avoidable complications linked to implantable devices is estimated at more than one billion euros per year. Reducing that risk — by documenting it, testing for it, and training the teams who face it daily — is the mission Gepromed has set itself since its creation in Strasbourg.
Goal: train and certify more than 4,000 professionals by 2030.
30 years of measured results
A research institution, not a marketing brand. Our work is published in peer-reviewed journals and our indicators are documented.
- Explant AnalysisEuropean Journal of Vascular and Endovascular Surgery
- Cardiovascular Device TestingJACC: Cardiovascular Interventions
- EducationScientific Reports
- 1,150+
- professionals trained since 2018
- 150+
- vascular explants received in 2023
- 20+
- clinical research studies
- 30
- years of failure analysis
30 years of peer-reviewed research
Upcoming trainings
Book your seat: sessions have limited capacity.
You built a device. Have it tested.
Independent mechanical and radiographic testing (ZEISS Xradia microscope, Faxitron system), ISO 13485 evaluation, and explant submission for failure analysis. One point of contact, from protocol to report.
- ISO 13485Device design & testing
- ZEISS Xradia3D X-ray microscopy
- FaxitronHigh-resolution radiography
One point of contact, from protocol to report
Since 1993
From GEPROVAS to Gepromed
Born from Strasbourg's vascular expertise, Gepromed has grown into a hub for medical-device safety and surgical training. Our approach combines high-fidelity technical platforms, guidance from a network of expert supervisors, and scientific rigor.
Our full history1993
The origins: GEPROVAS
The work initiated in 1993 around vascular explant analysis lays the foundations of a unique expertise in medical-device safety in Strasbourg.
2018
Scaling up training
Training of healthcare professionals scales up: more than 1,150 practitioners trained since 2018 on dedicated technical platforms.
2020
Expansion across specialties
Training, R&D and explant-analysis activities are organized with the ophthalmology, orthopedics, hand surgery, neurosurgery, digestive, urological and gynecological teams (Profs Bourcier, Ehlinger, Liverneaux, Proust, Cebula, Romain).
2022
GEPROVAS becomes Gepromed
The new name Gepromed asserts a strong link with history, gives visibility to medical devices and structures the identity around the four levels of the implant cycle.
Serving practitioners since 1993
FAQ
Frequent questions
A training request for your team?
We build tailor-made sessions for hospitals, clinics and industry. Let's talk about your educational project.